Stockscreener 앱 받기
18.00
4.90%
0.84
전일 마감가:
$17.16
열려 있는:
$16.93
하루 거래량:
1.44M
Relative Volume:
0.78
시가총액:
$2.64B
수익:
$340.81M
순이익/손실:
$-419.65M
주가수익비율:
-6.3158
EPS:
-2.85
순현금흐름:
$-402.10M
1주 성능:
+3.21%
1개월 성능:
+6.13%
6개월 성능:
+31.48%
1년 성능:
-25.68%
1일 변동 폭
$16.87
$18.23
1주일 범위
$16.85
$18.23
52주 변동 폭
$10.57
$26.18
Denali Therapeutics Inc Stock (DNLI) Company Profile
명칭
Denali Therapeutics Inc
전화
(650) 866-8547
주소
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
DNLI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DNLI
Denali Therapeutics Inc
|
18.00 | 2.52B | 340.81M | -419.65M | -402.10M | -2.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-03-07 | 재개 | Morgan Stanley | Overweight |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2025-01-07 | 개시 | Robert W. Baird | Outperform |
| 2025-01-03 | 개시 | William Blair | Outperform |
| 2024-12-16 | 업그레이드 | Stifel | Hold → Buy |
| 2024-10-10 | 재개 | Raymond James | Mkt Perform |
| 2024-10-07 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-13 | 개시 | Citigroup | Buy |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-10-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2023-09-06 | 개시 | B. Riley Securities | Buy |
| 2023-01-30 | 개시 | SVB Securities | Outperform |
| 2022-12-05 | 개시 | Cowen | Outperform |
| 2022-11-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-02 | 개시 | BofA Securities | Buy |
| 2022-06-23 | 개시 | Berenberg | Buy |
| 2021-12-10 | 재개 | Raymond James | Mkt Perform |
| 2021-09-21 | 개시 | Oppenheimer | Outperform |
| 2021-09-01 | 개시 | SMBC Nikko | Outperform |
| 2021-05-18 | 개시 | UBS | Buy |
| 2021-02-26 | 재확인 | H.C. Wainwright | Buy |
| 2021-02-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-11-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-09-14 | 재개 | JP Morgan | Overweight |
| 2020-08-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-02-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2020-02-24 | 개시 | Jefferies | Buy |
| 2020-02-19 | 개시 | Stifel | Hold |
| 2020-01-27 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-09-26 | 개시 | Wedbush | Neutral |
| 2019-09-13 | 개시 | Nomura | Buy |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-06-26 | 개시 | H.C. Wainwright | Buy |
| 2018-11-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 개시 | Janney | Buy |
| 2018-03-12 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2018-01-02 | 개시 | Evercore ISI | Outperform |
| 2018-01-02 | 개시 | Goldman | Neutral |
| 2018-01-02 | 개시 | JP Morgan | Overweight |
| 2018-01-02 | 개시 | Morgan Stanley | Overweight |
모두보기
Denali Therapeutics Inc 주식(DNLI)의 최신 뉴스
Transcript : Denali Therapeutics Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 12 - MarketScreener
How Denali Therapeutics Inc. stock trades during market volatility2025 Volatility Report & Reliable Trade Execution Plans - newser.com
How risky is Denali Therapeutics Inc. (4DN) stock compared to peers - newser.com
Denali Therapeutics announces board and leadership changes By Investing.com - Investing.com Nigeria
How strong dollar benefits Denali Therapeutics Inc. (4DN) stockJuly 2025 Trends & Community Consensus Picks - newser.com
Why Denali Therapeutics Inc. (4DN) stock benefits from AI revolution2025 Stock Rankings & Real-Time Volume Triggers - newser.com
Is Denali Therapeutics Inc. (4DN) stock at risk of policy regulationTrade Risk Report & AI Based Buy and Sell Signals - newser.com
Is Denali Therapeutics Inc. stock a defensive play in 2025Market Risk Summary & Risk Managed Investment Strategies - newser.com
Will Denali Therapeutics Inc. stock gain from lower inflationSwing Trade & High Conviction Investment Ideas - newser.com
Is Denali Therapeutics Inc. stock a contrarian buy2025 Trade Ideas & Accurate Buy Signal Notifications - newser.com
Is Denali Therapeutics Inc. (4DN) stock positioned for digital growth eraQuarterly Investment Review & Capital Efficient Trade Techniques - newser.com
Published on: 2025-11-19 17:06:18 - newser.com
Can Denali Therapeutics Inc. (4DN) stock resist broad market declinesTrade Exit Summary & Weekly Stock Breakout Alerts - newser.com
Applying sector rotation models to Denali Therapeutics Inc.Quarterly Risk Review & Weekly Return Optimization Alerts - newser.com
How Denali Therapeutics Inc. (4DN) stock performs in easing cyclesJuly 2025 Institutional & Momentum Based Trading Ideas - newser.com
Denali Therapeutics Inc. (4DN.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Denali Therapeutics Inc. stock supported by strong cash flowsEarnings Miss & Daily Volume Surge Trade Alerts - newser.com
Will Denali Therapeutics Inc. (4DN) stock outperform small cap peers2025 Price Momentum & Reliable Trade Execution Plans - newser.com
Why Denali Therapeutics Inc. stock remains on watchlists2025 Top Decliners & Technical Buy Zone Confirmations - newser.com
Will Denali Therapeutics Inc. (4DN) stock beat international competitionJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - newser.com
Why Denali Therapeutics Inc. stock is favored by pension fundsTrade Analysis Report & Verified Swing Trading Watchlist - newser.com
Will Denali Therapeutics Inc. stock outperform Nasdaq indexIndex Update & Weekly High Return Stock Forecasts - newser.com
Denali Therapeutics Inc (DNLI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):